Based on the AptarGroup Inc stock forecast from 4 analysts, the average analyst target price for AptarGroup Inc is USD 181.20 over the next 12 months. AptarGroup Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of AptarGroup Inc is Slightly Bullish , which is based on 7 positive signals and 4 negative signals. At the last closing, AptarGroup Inc’s stock price was USD 153.45. AptarGroup Inc’s stock price has changed by -1.32% over the past week, -10.60% over the past month and +21.37% over the last year.
No recent analyst target price found for AptarGroup Inc
No recent average analyst rating found for AptarGroup Inc
Company Overview AptarGroup Inc
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, and aerosol valves to the digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois. Read Less
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, ...Read More
Frequently Asked Questions About AptarGroup Inc (ATR) Stock
Based on ratings from 4 analysts AptarGroup Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 4 buy, sell and 1 hold ratings.
ATR stock's dividend yield is 1.17%.
Our analysis grades ATR stock's dividend yield at D. This means that ATR stock's dividend yield is above 63% of the stocks in the Medical Instruments & Supplies sector in the NYE exchange.
Based on this ATR may be a average dividend stock for its sector.
Based on targets from 4 analysts, the average taret price for ATR is USD 181.20 over the next 12 months. The maximum analyst target price is USD 200 while the minimum anlayst target price is USD 168.
ATR stock's Price/Earning ratio is 30.98.
Our analysis grades ATR stock's Price / Earning ratio at A-. This means that ATR stock's Price/Earning ratio is above 8.999999999999996% of the stocks in the Medical Instruments & Supplies sector in the NYE exchange.
Based on this ATR may be undervalued for its sector.
The last closing price of ATR's stock was USD 153.45.
The most recent market capitalization for ATR is USD 10.35B.
Based on targets from 4 analysts, the average taret price for ATR is projected at USD 181.20 over the next 12 months.
This means that ATR's stock price may go up by +18.08% over the next 12 months.
We can't find any ETFs which contains AptarGroup Inc's stock.
As per our most recent records AptarGroup Inc has 13,000 Employees.
AptarGroup Inc's registered address is 265 Exchange Drive, Crystal Lake, IL, United States, 60014.
You can get more information about it from AptarGroup Inc's website at https://www.aptar.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About AptarGroup Inc (ATR) Stock
Based on ratings from 4 analysts AptarGroup Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 4 buy, sell and 1 hold ratings.
ATR stock's dividend yield is 1.17%.
Our analysis grades ATR stock's dividend yield at D. This means that ATR stock's dividend yield is above 63% of the stocks in the Medical Instruments & Supplies sector in the NYE exchange.
Based on this ATR may be a average dividend stock for its sector.
Based on targets from 4 analysts, the average taret price for ATR is USD 181.20 over the next 12 months. The maximum analyst target price is USD 200 while the minimum anlayst target price is USD 168.
ATR stock's Price/Earning ratio is 30.98.
Our analysis grades ATR stock's Price / Earning ratio at A-. This means that ATR stock's Price/Earning ratio is above 8.999999999999996% of the stocks in the Medical Instruments & Supplies sector in the NYE exchange.
Based on this ATR may be undervalued for its sector.
The last closing price of ATR's stock was USD 153.45.
The most recent market capitalization for ATR is USD 10.35B.
Based on targets from 4 analysts, the average taret price for ATR is projected at USD 181.20 over the next 12 months.
This means that ATR's stock price may go up by +18.08% over the next 12 months.
We can't find any ETFs which contains AptarGroup Inc's stock.
As per our most recent records AptarGroup Inc has 13,000 Employees.
AptarGroup Inc's registered address is 265 Exchange Drive, Crystal Lake, IL, United States, 60014.
You can get more information about it from AptarGroup Inc's website at https://www.aptar.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ATR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
